PRIVIA HEALTH GROUP INC (PRVA)
US74276R1023 - Common Stock
We assign a fundamental rating of 5 out of 10 to PRVA. PRVA was compared to 117 industry peers in the Health Care Providers & Services industry. PRVA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PRVA shows excellent growth, but is valued quite expensive already. These ratings could make PRVA a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
PRVA had positive earnings in the past year.
In the past year PRVA had a positive cash flow from operations.
In multiple years PRVA reported negative net income over the last 5 years.
Each year in the past 5 years PRVA had a positive operating cash flow.
1.2 Ratios
PRVA's Return On Assets of 2.30% is fine compared to the rest of the industry. PRVA outperforms 68.10% of its industry peers.
The Return On Equity of PRVA (4.10%) is better than 68.97% of its industry peers.
PRVA has a Return On Invested Capital of 2.44%. This is comparable to the rest of the industry: PRVA outperforms 52.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.3% | ||
| ROE | 4.1% | ||
| ROIC | 2.44% |
ROA(3y)-8.73%
ROA(5y)-2.74%
ROE(3y)-13.9%
ROE(5y)-2.6%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PRVA has a better Profit Margin (1.39%) than 65.52% of its industry peers.
PRVA's Profit Margin has declined in the last couple of years.
The Operating Margin of PRVA (1.24%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of PRVA has grown nicely.
With a Gross Margin value of 9.74%, PRVA is not doing good in the industry: 79.31% of the companies in the same industry are doing better.
PRVA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.24% | ||
| PM (TTM) | 1.39% | ||
| GM | 9.74% |
OM growth 3Y-26.28%
OM growth 5Y30.07%
PM growth 3Y-28.56%
PM growth 5YN/A
GM growth 3Y-1.22%
GM growth 5Y2.55%
2. Health
2.1 Basic Checks
PRVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PRVA has more shares outstanding
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.82 indicates that PRVA is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.82, PRVA belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.82 |
ROIC/WACC0.26
WACC9.22%
2.3 Liquidity
PRVA has a Current Ratio of 1.81. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.81, PRVA is doing good in the industry, outperforming 69.83% of the companies in the same industry.
A Quick Ratio of 1.81 indicates that PRVA should not have too much problems paying its short term obligations.
PRVA has a Quick ratio of 1.81. This is in the better half of the industry: PRVA outperforms 72.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 46.15% over the past year.
PRVA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.87% yearly.
Looking at the last year, PRVA shows a very strong growth in Revenue. The Revenue has grown by 22.20%.
Measured over the past years, PRVA shows a very strong growth in Revenue. The Revenue has been growing by 20.31% on average per year.
EPS 1Y (TTM)46.15%
EPS 3Y-14.87%
EPS 5YN/A
EPS growth Q2Q-85.71%
Revenue 1Y (TTM)22.2%
Revenue growth 3Y26.59%
Revenue growth 5Y20.31%
Revenue growth Q2Q20.97%
3.2 Future
The Earnings Per Share is expected to grow by 33.38% on average over the next years. This is a very strong growth
Based on estimates for the next years, PRVA will show a small growth in Revenue. The Revenue will grow by 5.59% on average per year.
EPS Next Y29.99%
EPS Next 2Y33.39%
EPS Next 3Y33.38%
EPS Next 5YN/A
Revenue Next Year1.26%
Revenue Next 2Y7.72%
Revenue Next 3Y9.47%
Revenue Next 5Y5.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PRVA is valuated quite expensively with a Price/Earnings ratio of 98.63.
The rest of the industry has a similar Price/Earnings ratio as PRVA.
Compared to an average S&P500 Price/Earnings ratio of 28.28, PRVA is valued quite expensively.
A Price/Forward Earnings ratio of 75.88 indicates a quite expensive valuation of PRVA.
The rest of the industry has a similar Price/Forward Earnings ratio as PRVA.
The average S&P500 Price/Forward Earnings ratio is at 20.88. PRVA is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 98.63 | ||
| Fwd PE | 75.88 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as PRVA.
65.52% of the companies in the same industry are more expensive than PRVA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.56 | ||
| EV/EBITDA | 66.11 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRVA does not grow enough to justify the current Price/Earnings ratio.
PRVA's earnings are expected to grow with 33.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.29
PEG (5Y)N/A
EPS Next 2Y33.39%
EPS Next 3Y33.38%
5. Dividend
5.1 Amount
No dividends for PRVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PRIVIA HEALTH GROUP INC
NASDAQ:PRVA (5/3/2024, 7:13:32 PM)
After market: 18.74 0 (0%)18.74
+0.33 (+1.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.22B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 98.63 | ||
| Fwd PE | 75.88 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.29
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.3% | ||
| ROE | 4.1% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.24% | ||
| PM (TTM) | 1.39% | ||
| GM | 9.74% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.81 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)46.15%
EPS 3Y-14.87%
EPS 5Y
EPS growth Q2Q
EPS Next Y29.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)22.2%
Revenue growth 3Y26.59%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y